Mohammad Mahdi Ershadi | Biomedical Applications | Innovative Research Award

Published on by Computer Vision Awards

Innovative Research Award

    Mohammad Mahdi Ershadi
Affiliation Amirkabir University of Technology
Country Iran
Scopus ID 57212585059
Documents 22
Citations 196
h-index 10
Subject Area Biomedical Applications
Event Global Tech Excellence Awards
ORCID 0000-0002-7409-6469

Mohammad Mahdi Ershadi, affiliated with Amirkabir University of Technology, has established an emerging research profile in biomedical applications through interdisciplinary studies involving medical imaging, machine learning, and healthcare data analytics. His publications demonstrate contributions toward artificial intelligence methods for clinical decision support and image analysis while maintaining active scholarly engagement within internationally indexed research platforms.[1]

Abstract

Mohammad Mahdi Ershadi has developed a focused research portfolio in biomedical applications by integrating artificial intelligence, medical image analysis, and healthcare data interpretation. His publications investigate advanced segmentation methods, ensemble learning strategies, and data quality assessment for clinical decision support. Indexed scholarly outputs, measurable citation performance, and interdisciplinary collaboration collectively demonstrate a growing academic influence. These contributions support innovation in healthcare technologies while reflecting scientific rigor, reproducibility, and practical relevance. The documented research achievements indicate meaningful progress toward improving computational biomedical systems and advancing evidence-based medical analytics through modern intelligent computing methodologies.[1][2][3]

Keywords

Biomedical Applications, Artificial Intelligence, Medical Imaging, Chest X-ray Analysis, Machine Learning, Deep Learning, Ensemble Learning, Image Segmentation, Healthcare Analytics, Clinical Decision Support.

Introduction

The research activities of Mohammad Mahdi Ershadi emphasize computational intelligence for biomedical applications, particularly medical imaging and healthcare analytics. His interdisciplinary investigations combine artificial intelligence with clinical datasets to improve diagnostic reliability, segmentation accuracy, and decision-support methodologies, contributing practical scientific value within contemporary biomedical engineering research.[1]

Research Profile

According to indexed academic records, the researcher has authored twenty-two scholarly documents, received one hundred ninety-six citations, and achieved an h-index of ten. These indicators demonstrate sustained publication activity and increasing scholarly recognition within biomedical applications, machine learning, and computational healthcare research communities internationally.[1]

Research Contributions

Major research contributions include intelligent chest X-ray segmentation, ensemble learning for respiratory disease diagnosis, and investigations into data quality metadata supporting evidence-based decision making. These studies integrate advanced machine learning algorithms with healthcare applications, encouraging accurate medical interpretation and computational innovation across biomedical environments.[1][2]

Publications

The publication portfolio reflects consistent contributions to internationally recognized journals and scholarly platforms focusing on artificial intelligence, medical image processing, and biomedical engineering. Research outputs demonstrate methodological development, experimental validation, and practical healthcare relevance, supporting continuous academic advancement through peer-reviewed scientific dissemination.[1][3]

Research Impact

Citation metrics, interdisciplinary collaborations, and practical biomedical applications collectively indicate growing research impact. The published studies support advancements in healthcare technologies through robust computational methods, while influencing ongoing investigations involving medical image interpretation, clinical analytics, and intelligent diagnostic systems across international scientific communities.[1][2]

Award Suitability

Considering documented publication performance, measurable citation indicators, interdisciplinary biomedical research, and internationally indexed scholarly contributions, Mohammad Mahdi Ershadi demonstrates qualifications consistent with recognition under the Innovative Research Award. His scientific achievements illustrate meaningful advancement of intelligent healthcare technologies through rigorous academic investigation and innovation.[1][3]

Conclusion

Mohammad Mahdi Ershadi has established an emerging academic profile characterized by interdisciplinary biomedical research, measurable scholarly impact, and contributions to artificial intelligence for healthcare. Continued publication activity and collaborative scientific engagement are expected to strengthen future influence while supporting innovations addressing contemporary medical and computational challenges.[1][2][3]

References

  1. Ershadi, M. M., et al. (2026). Entropy-guided semi-supervised framework for robust chest X-ray segmentation using dynamic competition and patch-wise contrastive learning. Biomedical Signal Processing and Control.
    https://www.sciencedirect.com/science/article/abs/pii/S1746809426004878?via%3Dihub
  2. Ershadi, M. M., et al. (2025). Decoding DQM for Experimental Insights on Data Quality Metadata’s Impact on Decision-Making Process Efficacy.
    https://www.scopus.com/pages/publications/105023471399
  3. Ershadi, M. M., et al. (2025). Application of Ensemble Learning for Respiratory Ailment Diagnosis: Case Studies on Biomedical and Chest X-ray Image Datasets. Qeios.
    https://www.qeios.com/read/1NMNYE.3
  4. Elsevier. (n.d.). Scopus Author Details: Mohammad Mahdi Ershadi, Author ID 57212585059. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57212585059

Xiangu Chen | Biomedical and Healthcare Applications | Best Research Article Award

Published on by Computer Vision Awards

Prof. Xianguo Chen | Biomedical and Healthcare Applications | Best Research Article Award

Professor | Zhejiang University School of Medicine | China

Dr. Xianguo Chen is an active researcher in the field of lung cancer biology, molecular oncology, and precision medicine, with a strong focus on exploring genetic alterations, therapeutic resistance mechanisms, and biomarker-driven clinical translation. Affiliated with the Zhejiang University School of Medicine, Dr. Chen has established a robust research portfolio, contributing 16 scientific publications, accumulating 48 citations, and maintaining an h-index of 4, reflecting consistent scholarly impact within a rapidly evolving biomedical landscape.Dr. Chen’s research spans critical areas of lung adenocarcinoma, non-small cell lung cancer (NSCLC), oncogenic signaling pathways, and clinical molecular diagnostics. His work includes multiple contributions as first author, corresponding author, and co-corresponding author, demonstrating scientific leadership and collaboration across multidisciplinary teams. Notable publications include studies on miR-1293–mediated angiogenesis regulation, carbonic anhydrase 4 as a prognostic biomarker, and the identification of novel RET and ALK fusions in NSCLC, each contributing valuable insights into cancer progression, heterogeneity, and precision-targeted therapy.His commitment to translational oncology is further reflected in several research grants. These include major funded projects focused on acacetin-mediated SMYD2 inhibition and DNA damage repair, KMT3C-driven osimertinib resistance via ENO1-regulated glycolysis, and metabolomic discrimination of pulmonary nodules combined with fecal microbiota transplantation strategies. These funded studies highlight his expertise in integrating molecular biology, bioinformatics, and therapeutic research to address pressing clinical challenges in cancer diagnosis and treatment.In addition to his publication record, Dr. Chen engages in collaborative research involving over 130 co-authors, demonstrating broad interdisciplinary partnerships across medical, molecular, and computational sciences. His recent article on machine learning–based immune prognosis modeling for lung adenocarcinoma extends his contributions into the domain of AI-assisted oncology, reinforcing the relevance of computational technologies in modern cancer research.Dr. Chen’s scientific efforts collectively aim to enhance early cancer detection, refine prognostic tools, and illuminate new molecular targets for therapy. Through his funded projects, high-quality publications, and sustained collaborative activity, he continues to contribute significantly to the advancement of global lung cancer research and its transition toward more personalized, mechanism-driven clinical care.

Profiles: Scopus | ResearchGate

Featured Publication

1.Construction and validation of immune prognosis model for lung adenocarcinoma based on machine learning. (2025). Frontiers in Oncology.

Dr. Xianguo Chen research advances precision oncology by uncovering molecular mechanisms that drive lung cancer progression and therapeutic resistance, enabling more accurate diagnostics and targeted treatment strategies.

Shenglin Wang | Biomedical and Healthcare Applications | Young Scientist Award

Published on by Computer Vision Awards

Dr. Shenglin Wang | Biomedical and Healthcare Applications | Young Scientist Award

Clinician-Scientist | Fujian Medical University | China

Dr. Shenglin Wang is a biomedical researcher whose work focuses on tumor biology, cancer metastasis, and molecular mechanisms underlying osteosarcoma, chondrosarcoma, and lung cancer bone lesions. He completed a Post-doctoral Fellowship at Fujian Medical University where he advanced single-cell sequencing, tumor microenvironment profiling, and molecular pathology research. In 2025, he joined The First Affiliated Hospital of Fujian Medical University as a Physician, continuing to integrate clinical oncology with translational cancer research.Over the last five years, Dr. Wang has secured three competitive research grants as Principal Investigator or Co-Investigator. His ongoing NSFC project  investigates SOX18-mediated endothelial senescence and HBEGF secretion in non-small cell lung cancer bone metastasis, aiming to define novel therapeutic targets within the senescent vascular niche. He also leads a provincial project exploring HMGA2-regulated ferroptosis resistance in chondrosarcoma, contributing to the understanding of tumor progression and cell death mechanisms. His completed NSFC project, focused on aptamer-based electrochemical sensing for rapid detection of circulating tumor cells, reflects his multidisciplinary approach combining bioengineering with oncology.Dr. Wang has authored 33 peer-reviewed publications, accumulating 651 citations, with an h-index of 11, demonstrating sustained research productivity and academic impact. His representative articles include studies in Cell Proliferation, Frontiers in Immunology, and Acta Biochimica et Biophysica Sinica, covering topics such as single-cell transcriptomics of metastatic bone microenvironments, immune regulatory networks in thyroid carcinoma, and STAT3/EGFR signaling in osteosarcoma drug resistance. His collaborative work spans more than 60 co-authors, highlighting strong interdisciplinary engagement.Collectively, Dr. Wang’s research advances understanding of tumor microenvironment remodeling, therapeutic resistance, and metastasis-associated cell senescence. His contributions support the development of precision oncology strategies and have broad implications for improving diagnostic, prognostic, and therapeutic outcomes in bone-related malignancies.

Profiles:  Scopus | ResearchGate

Featured Publications

1. Author(s). (2025). The integrin α2–osteoclast axis: A key driver of bone destruction and therapeutic target in osteosarcoma. Journal of Translational Medicine.

2. Author(s). (2021). Corrigendum: Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway. Acta Biochimica et Biophysica Sinica, 53(12), 1670–1680.

3. Author(s). (2025). Single-cell transcriptomic analysis of the senescent microenvironment in bone metastasis. Cell Proliferation, 58(1), e13743. Cited By : 5

The nominee’s work advances precision oncology by uncovering key molecular and microenvironmental mechanisms that drive tumor progression, therapeutic resistance, and bone metastasis, enabling the development of more effective diagnostic and therapeutic strategies. By integrating single-cell analytics, molecular signaling research, and translational innovation, the nominee contributes to improved cancer outcomes and supports global efforts toward personalized, mechanism-driven cancer care.